Frequently Asked Questions about AXIM Biotechnologies, Inc. (AXIM)

Name: AXIM Biotechnologies, Inc. (AXIM) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does AXIM Biotechnologies, Inc. (AXIM) do?

Accepted Answer

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; ...

Question 2

Is AXIM Biotechnologies, Inc. (AXIM) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of AXIM reveals an Altman Z-Score of -35.87 and a Piotroski F-Score of 0/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if AXIM fits their risk profile.

Question 3

What is the current P/E ratio for AXIM?

Accepted Answer

As of the latest trading session, AXIM Biotechnologies, Inc. (AXIM) has a trailing P/E ratio of -3.88.

Question 4

Who is the CEO of AXIM Biotechnologies, Inc.?

Accepted Answer

The current Chief Executive Officer of AXIM Biotechnologies, Inc. is Catalina Valencia.

Question 5

What was AXIM's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, AXIM Biotechnologies, Inc. reported annual revenues of $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021), $0.00B (2020) respectively.

Question 6

Does AXIM pay a dividend?

Accepted Answer

AXIM Biotechnologies, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does AXIM have?

Accepted Answer

In its latest reporting period, AXIM Biotechnologies, Inc. generated $-0.00B in Free Cash Flow against a total debt load of $0.01B.

Question 8

What is the Price-to-Book (P/B) ratio of AXIM Biotechnologies, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for AXIM Biotechnologies, Inc. (AXIM) is currently -0.19.

Question 9

What is the Price-to-Sales (P/S) ratio of AXIM?

Accepted Answer

Based on trailing twelve-month data, AXIM Biotechnologies, Inc. (AXIM) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is AXIM Biotechnologies, Inc.'s Return on Equity (ROE)?

Accepted Answer

AXIM Biotechnologies, Inc. (AXIM) has a Return on Equity (ROE) of 4.91%, representing its profitability relative to shareholder equity.